Armstrong Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236K Hold
1,833
0.01% 226
2026
Q1
$220K Hold
1,833
0.01% 229
2025
Q4
$193K Hold
1,833
0.01% 229
2025
Q3
$154K Hold
1,833
0.01% 247
2025
Q2
$145K Sell
1,833
-804
-30% -$63.9K 0.01% 239
2025
Q1
$262K Hold
2,637
0.02% 162
2024
Q4
$262K Buy
2,637
+1
+0% +$103 0.02% 162
2024
Q3
$299K Sell
2,636
-35
-1% -$4.16K 0.02% 152
2024
Q2
$331K Sell
2,671
-62
-2% -$7.99K 0.03% 133
2024
Q1
$298K Hold
2,733
0.03% 141
2023
Q4
$298K Hold
2,733
0.03% 141
2023
Q3
$281K Sell
2,733
-38
-1% -$4.1K 0.03% 134
2023
Q2
$320K Sell
2,771
-273
-9% -$31K 0.03% 124
2023
Q1
$324K Hold
3,044
0.04% 118
2022
Q4
$338K Buy
+3,044
New +$311K 0.04% 118

Other funds holding MRK

Armstrong Advisory Group's MRK Position: Q2 2026 in Review

Armstrong Advisory Group held its Merck (MRK) position steady in Q2 2026 at 1,833 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #226.

Armstrong Advisory Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $338K in Q4 2022. 1,552 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Armstrong Advisory Group held 1,833 shares of Merck worth $236K as of Q2 2026.
  • Armstrong Advisory Group left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #226 holding.
  • Armstrong Advisory Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Merck position peaked at $338K in Q4 2022.
  • 1,552 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.